It supports instructional use within research, teaching, and simulation facilities where a preserved water-based medium is required
However, the evidence for superiority over subcutaneous administration remains unclear, and the increased complexity and discomfort of IM injection discourages its use for most individuals
Both the Wegovy pill and the Wegovy pen contain the same active ingredient, semaglutide, and are FDA-approved for weight management
Disadvantages involve benefit decline during off periods requiring acceptance of fluctuation, complexity planning and tracking cycles, uncertainty about optimal timing and duration for individual responses, and potential for forgetting to restart after extended breaks
*All peptide sales are nonrefundable and nonreturnable